PMC:7443692 / 19196-19294 JSONTXT

{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T133","span":{"begin":43,"end":55},"obj":"Chemical"}],"attributes":[{"id":"A133","pred":"chebi_id","subj":"T133","obj":"http://purl.obolibrary.org/obo/CHEBI_24396"}],"text":" to the SARS-CoV-2 S immunogen to maximize glycopeptide coverage by subsequent LC-MS/MS analyses. "}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T60","span":{"begin":8,"end":18},"obj":"Species"}],"attributes":[{"id":"A60","pred":"ncbi_taxonomy_id","subj":"T60","obj":"NCBItxid:2697049"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":" to the SARS-CoV-2 S immunogen to maximize glycopeptide coverage by subsequent LC-MS/MS analyses. "}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T44","span":{"begin":8,"end":18},"obj":"Disease"}],"attributes":[{"id":"A44","pred":"mondo_id","subj":"T44","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":" to the SARS-CoV-2 S immunogen to maximize glycopeptide coverage by subsequent LC-MS/MS analyses. "}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T76","span":{"begin":43,"end":55},"obj":"Body_part"}],"attributes":[{"id":"A76","pred":"fma_id","subj":"T76","obj":"http://purl.org/sig/ont/fma/fma82784"}],"text":" to the SARS-CoV-2 S immunogen to maximize glycopeptide coverage by subsequent LC-MS/MS analyses. "}